SKYE
Skye Bioscience Inc.
$3.89
-$0.11(-2.75%)
30
Overall
--
Value
30
Tech
--
Quality
Market Cap
$123.95M
Volume
417.92K
52W Range
$1.14 - $5.96
Target Price
$15.71
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $-48.6K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Total Revenue | $-48.6K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $-4.5M | $-3.9M | $-4.7M | $6.6M | $6.3M | $7.8M | $18.3M | $34.7M | $30.2M | ||
| Research & development expense | $939.0K | $311.3K | $330.0K | $2.2M | $1.9M | $2.9M | $6.0M | $5.8M | $18.7M | ||
| Research Expense | $939.0K | $311.3K | $330.0K | $2.2M | $1.9M | $2.9M | $6.0M | $5.8M | $18.7M | ||
| Selling & Marketing Expenses | -- | $-767.2K | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $3.5M | $3.5M | $4.4M | $4.4M | $4.3M | $4.9M | $6.1M | $7.9M | $17.7M | ||
| Salaries & Wages | -- | $-608.7K | $-675.0K | $-680.5K | $302.7K | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-1.3M | -- | -- | -- | -- | -- | -- | $49.9K | $203.8K | ||
| Amortization of intangibles | $-1.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | $-552.1K | $-585.8K | $-687.6K | $-1.1M | -- | -- | ||
| OPERATING INCOME | |||||||||||
| Operating income | $-4.5M | $-3.1M | $-4.7M | $-6.6M | $-6.3M | $-7.8M | $-18.3M | $-34.7M | $-30.2M | ||
| EBITDA | $-3.1M | $-3.1M | $-19.0M | $2.7M | $-5.9M | $-7.7M | $-18.7M | $-36.3M | $-24.9M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | -- | $667 | $94.8K | $1.0M | $706.4K | $769.2K | $665.1K | $906.3K | $749.3K | ||
| Interest income | -- | -- | $-13.7M | $9.4M | $29 | $3 | $19.0K | $100.0K | $3.0M | ||
| Net Non-Operating Interest Income/Expense | -- | $-667 | $-13.8M | $8.4M | $-706.4K | $-769.2K | $766.4K | $-806.3K | $2.3M | ||
| Other Special Charges | $1.3M | $-767.2K | $-590.4K | $-725.4K | $-436.3K | $139.1K | $517.0K | $-1.4M | $-2.2K | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-3.2M | $-3.1M | $-19.1M | $2.1M | $-5.9M | $-7.8M | $-18.8M | $-36.7M | $-25.8M | ||
| NET INCOME | |||||||||||
| Diluted normalized net income/share | -- | -- | -- | $-12.5 | $-7.5 | $-5 | $-10 | $-5.37 | $-0.73 | ||
| Net Income (Continuing Operations) | $-3.2M | $-3.1M | $-19.2M | $1.1M | $-6.6M | $-8.5M | $-19.5M | $-37.6M | $-26.6M | ||
| Net Income (Common Stockholders) | $-3.5M | $-4.1M | $-19.2M | $1.1M | $-6.6M | $-8.5M | $-19.5M | $-37.6M | $-26.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-6.7M | -- | -- | -- | ||
| TOTALS | |||||||||||
| Total Expenses | $-4.5M | $-3.9M | $-4.7M | $6.6M | $6.3M | $7.8M | $12.1M | $34.7M | $30.2M | ||
| SHARE & EPS DATA | |||||||||||
| Basic weighted shares outstanding | $18.9M | $27.9M | $121.2M | $540.6K | $923.0K | $1.6M | $2.2M | $7.0M | $36.5M | ||
| Basic E P S from continuing operations | -- | -- | -- | $2.5 | $-7.5 | $-5 | $-10 | $-5.37 | $-0.73 | ||
| Diluted E P S total | $-0.17 | $-0.11 | $-0.16 | $-12.5 | $-7.5 | $-5 | $-10 | $-5.37 | $-0.73 | ||
| OTHER METRICS | |||||||||||
| Accrued Preferred Stock Dividends | $325.0K | $1.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | $-48.6K | -- | $-137.2K | -- | -- | -- | -- | -- | -- | ||
| Basic E P S total | $-0.17 | $-0.11 | $-0.16 | $2.5 | $-7.5 | $-5 | $-10 | $-5.37 | $-0.73 | ||
| Depreciation unreconciled | $-1.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Diluted weighted shares outstanding | $18.9M | $28.1M | $121.2M | $678.2K | $925.7K | $1.6M | $2.2M | $7.0M | $36.5M | ||
| Earnings from equity interest | -- | $102.8K | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | $102.8K | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | -- | -- | -- | -- | $-307.1K | $1.4M | ||
| Gain On Sale Of P P E | $-48.6K | $-1.8K | $-7.2M | -- | -- | -- | -- | -- | -- | ||
| Gross operating profit | $-48.6K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Income before tax | $-3.2M | $-3.1M | $-19.2M | $1.1M | $-6.6M | $-8.5M | $-19.5M | $-37.6M | $-26.6M | ||
| Income taxes | $1.6K | $1.6K | $1.6K | $1.6K | $1.6K | $2.1K | $6.7K | $3.6K | $10.1K | ||
| Marketing Expense | -- | $-767.2K | -- | -- | -- | -- | -- | -- | -- | ||
| Net income from total operations | $-3.2M | $-3.1M | $-19.2M | $1.1M | $-6.6M | $-8.5M | $-19.5M | $-37.6M | $-26.6M | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | $6.2M | $-151.8K | $-6.2M | ||
| Other income net | $-1.3M | $769.0K | $727.6K | $725.4K | $436.3K | $-139.1K | $-6.6M | $1.7M | $-1.4M | ||
| Other Gand A | $3.5M | $3.5M | $4.4M | $4.4M | $4.3M | $4.9M | $6.1M | $7.9M | $17.7M | ||
| Otherunder Preferred Stock Dividend | $325.0K | $1.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $325.0K | $1.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $3.5M | $3.5M | $4.4M | -- | -- | -- | -- | -- | -- | ||
| Revenue per share | $-1.3M | -- | -- | -- | $542.5K | $592.2K | $488.2K | $320.8K | $582.5K | ||
| Selling Gen & administrative expense | $3.5M | $2.8M | $4.4M | $4.4M | $4.3M | $4.9M | $6.1M | $7.9M | $17.7M | ||
| Special income/charges | -- | -- | -- | -- | -- | -- | $-6.2M | $151.8K | $6.2M | ||
| Total common shares outstanding | $25.7M | $100.1M | $133.9M | $732.8K | $1.4M | $2.0M | $3.9M | $28.1M | $31.0M | ||
| Total net income | $-3.2M | $-3.1M | $-19.2M | $1.1M | $-6.6M | $-8.5M | $-19.5M | $-37.6M | $-26.6M | ||
| Total ordinary shares | $31.0M | $31.0M | $31.0M | $31.0M | $31.0M | $31.0M | $31.0M | $31.0M | $31.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SKYE | $3.89 | -2.7% | 417.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |